Results 221 to 230 of about 71,955 (233)
Some of the next articles are maybe not open access.
Microwave ablation for the treatment of arterial epistaxis: “how I do it”
International Forum of Allergy and Rhinology, 2019Arterial epistaxis is commonly seen in the rhinology clinic and can have a significant impact on quality of life. Previous studies have explored various therapies to address epistaxis.
Z. Lou, Yihan Dong, Z. Lou
semanticscholar +1 more source
Sclerotherapy and Topical Nasal Propranolol: An Effective and Safe Therapy for HHT‐Epistaxis
The Laryngoscope, 2019Epistaxis is the most frequent clinical manifestation of hereditary hemorrhagic telangiectasia (HHT). Several topical, systemic, and surgical treatments have been tried, but none have been completely effective. The aim of the present study is to evaluate
S. Esteban-Casado+7 more
semanticscholar +1 more source
Topical Tranexamic Acid for the Treatment of Acute Epistaxis: A Systematic Review and Meta-analysis
The Annals of Pharmacotherapy, 2018Objective: To compare topical tranexamic acid (TXA) with control groups for the treatment of acute epistaxis assessing bleeding cessation, discharge within 2 hours, rebleeding rates, complication rates, and patient satisfaction.
M. Gottlieb, Joshua M. DeMott, G. Peksa
semanticscholar +1 more source
The Egyptian Journal of Hospital Medicine, 2019
Background: epistaxis is a fairly common problem, which has been reported to be occurring in about 60% of the population. It defined as a bleeding from nose or nasal cavity and it is considered as one of the most common emergencies presenting in Ear ...
Mohammed A. Alhejaily+3 more
semanticscholar +1 more source
Background: epistaxis is a fairly common problem, which has been reported to be occurring in about 60% of the population. It defined as a bleeding from nose or nasal cavity and it is considered as one of the most common emergencies presenting in Ear ...
Mohammed A. Alhejaily+3 more
semanticscholar +1 more source
Journal of Laryngology and Otology, 2018
BACKGROUND Hereditary haemorrhagic telangiectasia is an autosomal dominant condition, characterised by mucocutaneous telangiectasia, aneurysm and arteriovenous malformations. Thalidomide has been used as a therapeutic strategy for refractory epistaxis in
L. Harrison, A. Kundra, P. Jervis
semanticscholar +1 more source
BACKGROUND Hereditary haemorrhagic telangiectasia is an autosomal dominant condition, characterised by mucocutaneous telangiectasia, aneurysm and arteriovenous malformations. Thalidomide has been used as a therapeutic strategy for refractory epistaxis in
L. Harrison, A. Kundra, P. Jervis
semanticscholar +1 more source
Identification of bleeding sites and microwave thermal ablation of posterior epistaxis
Acta Oto-Laryngologica, 2019Background: Microwave ablation (MWA) is a relatively new technique which has been used to achieve hemostasis at surgical field. However, few publications have reported MWA for epistaxis.
Z. Lou, Hong-fan Wei, Z. Lou
semanticscholar +1 more source
Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia
Angiogenesis, 2020D. D. Jel+4 more
semanticscholar +1 more source
Severe spontaneous epistaxis: retrospective study in a tertiary ENT centre
European Archives of Oto-Rhino-Laryngology, 2019Eline Marin+3 more
semanticscholar +1 more source
Emergency medicine clinics of North America, 2019
Neil Krulewitz, M. Fix
semanticscholar +1 more source
Neil Krulewitz, M. Fix
semanticscholar +1 more source